Will Antiangiogenic Agents be a Future for Mesothelioma Therapy?
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
3069-3079
Author(s):
C. Belli, S. Anand, M. Panella, M. Giovannini, G. Tassi, D. Fennell and L. Mutti
The Immunological Side-Effects of Sedative Agents in the Intensive Care Unit
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
9
Page:
229-237
Author(s):
A. Walsh and K. Ghori
A Wnt-ow of Opportunity: Targeting the Wnt/β-Catenin Pathway in Breast Cancer
Journal:
Current Drug Targets
Volume:
11
Page:
1074-1088
Author(s):
Jenifer R. Prosperi and Kathleen H. Goss
Hedgehog Signaling in the Normal and Neoplastic Mammary Gland
Journal:
Current Drug Targets
Volume:
11
Page:
1103-1111
Author(s):
Adriana P. Visbal and Michael T. Lewis
Targeting the Type I Insulin-Like Growth Factor System for Breast Cancer Therapy
Journal:
Current Drug Targets
Volume:
11
Page:
1121-1132
Author(s):
Deepali Sachdev
Targeting the Perpetrator: Breast Cancer Stem Cell Therapeutics
Journal:
Current Drug Targets
Volume:
11
Page:
1147-1156
Author(s):
Arindam Pal, Kelli E. Valdez, Martha Z. Carletti and Fariba Behbod
The Macrophage Stimulating Protein/Ron Pathway as a Potential Therapeutic Target to Impede Multiple Mechanisms Involved in Breast Cancer Progression
Journal:
Current Drug Targets
Volume:
11
Page:
1157-1168
Author(s):
Kelsi L. Kretschmann, Henok Eyob, Saundra S. Buys and Alana L. Welm
Tyrosine Kinase Receptor Transactivation Associated to G Protein-Coupled Receptors
Journal:
Current Drug Targets
Volume:
11
Page:
1169-1180
Author(s):
Vanessa Almendro, Susana Garcia-Recio and Pedro Gascon
Combined Therapies of Bone Disease with Bisphosphonates
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
2988-2997
Author(s):
S. P. Syddall, P. D. Ottewell and I. Holen
Radionuclide Molecular Imaging Using Affibody Molecules
Journal:
Current Pharmaceutical Biotechnology
Volume:
11
Page:
581-589
Author(s):
Sara Ahlgren and Vladimir Tolmachev